Family / Patient | Study | NIS | SNCS | MNCS | CTS | QST | CASS | Follow-up Time (years) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L ulnar SNAP amplitude (µV) | L sural SNAP amplitude (µV) | L ulnar CMAP amplitude (mV) | L fibular CMAP amplitude (mV) | L tibial CMAP amplitude (mV) | VDT LUL/LLL | CDT LUL/LLL | HPS LUL/LLL | ||||||
Patients with sensory and autonomic polyneuropathy at presentation. | |||||||||||||
A3a | 1st | 18 | 20.9a | 11 | 10a | 3.2 | 14.3 | Severe, R | +a/+ | +a/+ | +a/+ | 5 | 4 |
Last | 20 | 22a | 10 | 10.3a | 3.4 | 10.6 | Severe, R | +a/+ | +a/+ | +a/ + | 5 | ||
A4 | 1st | 10 | 20 | 11 | 8.3 | 3.2 | 15.7 | Mod, B | -/ - | -/+ | +/+ | 3 | 4 |
Last | 12 | 22 | 9.1 | 10.2 | 4.2 | 16.5 | Mod, B | -/ - | -/+ | +/+ | 3 | ||
A5 | 1st | 10 | 27 | 9.1 | 10.8 | 6 | 12.7 | A | -/+ | -/- | +/+ | 4 | 3 |
Last | 10 | 30 | 10.7 | 10.9 | 6.2 | 10.7 | A | -/+ | -/- | +/+ | 3 | ||
B2 | 1st | 12 | 16.8 | 11.3 | 10.4 | 3.3 | 11.1 | A | +/++ | -/+ | NA | 3 | 3 |
Last | 12 | 12.7 | 11.3 | 10.5 | 3.9 | 8.1 | A | +/++ | -/+ | NA | 4 | ||
Patients with sensory, motor and autonomic polyneuropathy at presentation. | |||||||||||||
A1 | 1st | 84 | NR | NR | 2.3 | NR | 0.8 | Severe, B | ++/++ | ++/++ | NA | NA | 6 (death) |
Last | 145 | NR | NR | NR | NR | NR | U | NA | NA | NA | NA | ||
A2 | 1st | 30 | 12.6 | 4.5 | 8.2 | 1.4 | 3.9 | Severe, B | ++/++ | -/+ | -/+ | 5 | 4 |
Last | 60 | 4.7 | NR | 5 | 0.5 | 1.3 | Severe, B | ++/++ | +/++ | +/++ | 7 | ||
B1 | 1st | 92 | NR | NR | 1.5 | NR | NR | Severe, B | ++/++ | ++/++ | ++/++ | NA | 3 (death) |
Last | 152 | NR | NR | NR | NR | NR | U | ++/++ | ++/++ | ++/++ | NA | ||
C1 | 1st | 72 | 8 | NR | 3.8 | NR | 4.2 | Severe, B | ++/++ | ++/++ | +/++ | 9 | 5 |
Last | 109 | 4.4 | NR | 2.5 | NR | 2.4 | Severe, B | ++/++ | ++/++ | ++/++ | NA | ||
D1 | 1st | 44 | 4.4 | 4 | 6.5 | 1.9 | 6 | Severe, R Mod, L | ++/++ | ++/++ | ++/++ | 6 | 5 |
Last | 66 | NR | NR | 6 | 1.2 | 3.5 | Severe, R Mod, L | ++/++ | ++/++ | NA | 7 |